SEER · NASDAQ · Biotechnology

Seer (SEER)

Provides the Proteograph platform for deep, unbiased proteomics research.

$1.86
After-hours close−0.01 (−0.53%)
At close$1.87(+0.54%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue443344444433
Cost of revenue423324222222
Gross profit120020222212
272425272624232321191818
Research & development1211111113111112111098
15131416131311111110910
General & administrative0000000000010
Other expenses000000000000
Operating income−26−22−25−27−24−24−21−21−19−17−17−17
545432111100
Interest income555444333322
Other non-operating income−5−4−5−4−3−200000−2
Income before tax−21−18−21−23−21−22−20−19−18−16−17−17
Income tax expense000000000000
Net income from continuing operations−21−18−21−23−21−22−20−19−18−16−17−17
Net income−21−18−21−23−21−22−20−19−18−16−17−17
EPS, basic−$0.33−$0.28−$0.32−$0.35−$0.35−$0.35−$0.34−$0.33−$0.32−$0.29−$0.30−$0.31
EPS, diluted−$0.33−$0.28−$0.32−$0.35−$0.35−$0.35−$0.34−$0.33−$0.32−$0.29−$0.30−$0.31
Weighted average shares, basic646465656161595856575655
Weighted average shares, diluted646465656161595856575655
EBITDA−20−16−19−21−20−20−19−19−18−16−16−15
Depreciation & amortization121222221220
EBIT−21−18−21−23−21−22−21−21−19−17−17−15